Differential secretion of atrial and brain natriuretic peptide in critically III patients

Anesthesia and Analgesia

Volumn 93, Issue 3, 2001, Pages 676-682

  Berendes, Elmar ^a   Van Aken, Hugo ^a   Raufhake, Carsten ^a   Schmidt, Christoph ^a   Assmann, Gerd ^a   Walter, Michael ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; SODIUM;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; SUBARACHNOID HEMORRHAGE; URINE OSMOLALITY;

EID: 0034874725     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200109000-00029     Document Type: Article

References (27)

1. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats
2. Natriuretic peptides
3. A new natriuretic peptide in porcine brain
4. Human brain natriuretic peptide-like immunoreactivity in human brain
5. Bioactivity and metabolism of C-type natriuretic peptide in normal man
6. Human C-type natriuretic peptide: Characterization of the gene and peptide
7. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption
8. The effect of a human atrial natriuretic peptide on plasma volume and vascular permeability in normotensive subjects
9. Differing biological effects of equimolar atrial and brain natriuretic peptide infusion in normal man
10. Brain natriuretic peptides: Differential localization of a new family of neuropeptides
11. Interactions between ANP and ANG II in regulating blood pressure and sympathetic outflow
12. Inhibition of vasopressin action by atrial natriuretic factor
13. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction
14. Natriuretic peptide system in human heart failure
15. Atrial natriuretic peptide elevation in congestive heart failure in the human
16. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction
17. Plasma atrial natriuretic factor and subarachnoid hemorrhage
18. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage
19. Inappropriate secretion of natriuretic peptides in a patient with a cerebral tumor
20. The role of angiotensin II in the development of peripheral vasoconstriction during open-heart surgery
21. Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass
22. Mechanical and neuroendocrine regulation of the endocrine heart
23. Na-test is of no prognostic value in acute renal failure
24. Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure
25. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
26. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction
27. New insights on the functions of the guanylyl cyclase receptors